Cost-Effectiveness of Low-Dose Compared to Standard-Dose Alteplase for Acute Ischemic Stroke in China: A Within-Trial Economic Evaluation of the ENCHANTED Study | Zendy

Lei Si | Zendy; Xiaoying Chen | Zendy; Menglu Ouyang | Zendy; Xia Wang | Zendy; Guofang Chen | Zendy; Yongjun Cao | Zendy; Guojun Wu | Zendy; Jinli Zhang | Zendy; Jingfen Zhang | Zendy; Yukai Liu | Zendy; Shihong Zhang | Zendy; Lili Song | Zendy; Candice Delcourt | Zendy; Hisatomi Arima | Zendy; Lidan Wang | Zendy; Thomas Lung | Zendy; Mingsheng Chen | Zendy; Craig S. Anderson | Zendy; Stephen Jan | Zendy

Open Access

Cost-Effectiveness of Low-Dose Compared to Standard-Dose Alteplase for Acute Ischemic Stroke in China: A Within-Trial Economic Evaluation of the ENCHANTED Study

Author(s) -

Lei Si,

Xiaoying Chen,

Menglu Ouyang,

Xia Wang,

Guofang Chen,

Yongjun Cao,

Guojun Wu,

Jinli Zhang,

Jingfen Zhang,

Yukai Liu,

Shihong Zhang,

Lili Song,

Candice Delcourt,

Hisatomi Arima,

Lidan Wang,

Thomas Lung,

Mingsheng Chen,

Craig S. Anderson,

Stephen Jan

Publication year - 2022

Publication title -

cerebrovascular diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.221

H-Index - 104

eISSN - 1421-9786

pISSN - 1015-9770

DOI - 10.1159/000525869

Subject(s) - medicine , confidence interval , thrombolysis , cost effectiveness , stroke (engine) , quality adjusted life year , modified rankin scale , emergency medicine , physical therapy , ischemic stroke , myocardial infarction , mechanical engineering , risk analysis (engineering) , ischemia , engineering

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research